போட்டி ஜெநெரிக் சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from போட்டி ஜெநெரிக் சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In போட்டி ஜெநெரிக் சிகிச்சை Today - Breaking & Trending Today

ANI Pharmaceuticals Inc (ANIP) Q1 2021 Earnings Call Transcript


Operator
Good day everyone, and welcome to today s ANI Pharmaceuticals First Quarter 2021 Earnings Release Call. [Operator Instructions]
It s now my pleasure to turn the conference over to Lisa Wilson. Please go ahead.
Lisa M. Wilson
Investor Relations
Thank you, operator. Welcome to ANI Pharmaceuticals Q1 2021 earnings results call. This is Lisa Wilson of In-Site Communications, Investor Relations for ANI. With me on today s call are Nikhil Lalwani, President and Chief Executive Officer; and Stephen Carey, Chief Financial Officer of ANI. You can also access the webcast of this call through the Investors section of the ANI website at anipharmaceuticals.com. ....

United States , Nikhil Lalwani , Lisam Wilson , Lisa Wilson , Stephen Carey , Sherry Korczynski , Chris Mutz , Stephenp Carey , Site Communications , Pharmaceuticals First Quarter , Ani Pharmaceuticals Inc , First Quarter , In Site Communications , Investor Relations , Chief Executive Officer , Chief Financial Officer , Private Securities Litigation Reform , Chief Executive , Cortrophin Gel , New Drug Application , Chief Commercial Officer , Rare Diseases , Bill Mroczka , Market Access , Competitive Generic Therapy , North American ,

Gland Pharma receives approval for generic Foscarnet Sodium Injection


Gland Pharma received approval from the United States Food and Drug Administration (US FDA) for generic Foscarnet Sodium Injection, 6000 mg/250 mL (24 mg/mL) Single-Dose Bag for Infusion.
Generic Foscarnet Sodium Injection is the bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Foscavir Injection, 24 mg/mL, of Clinigen Healthcare.
With this approval, Gland Pharma secured the first generic offering status in Single-Dose Bag for Infusion. Gland Pharma is backward integrated with in-house API source for this product. Gland Pharma intends to supply this product globally and recently launched the product in the Canadian market. Global markets size is estimated to be $50 million. ....

United States , Drug Administration , Gland Pharma , United States Food , Foscarnet Sodium Injection , Single Dose Bag , Reference Listed Drug , Foscavir Injection , Competitive Generic Therapy , Sodium Injection , Capital Market , ஒன்றுபட்டது மாநிலங்களில் , சுரப்பி பார்மா , ஒன்றுபட்டது மாநிலங்களில் உணவு , குறிப்பு பட்டியலிடப்பட்டுள்ளது மருந்து , போட்டி ஜெநெரிக் சிகிச்சை , சோடியம் ஊசி , மூலதனம் சந்தை ,